COVID-19: Universal Use of N95 Masks
& Community Risk Zones Should Be Based Upon Infections
Kevin Kavanagh, MD, MS from Health Watch USA(sm) provided the following
comment at the the CDC's Healthcare Infection Control Practices Advisory
Committee (HICPAC) Meeting. In summary, when masking is required, I
would like to encourage the CDC to require universal use of N95 masks.
And in view of the common and disabling effects of long COVID, the CDC
should revert to a community risk ranking strategy which is based upon
the rate of SARS-CoV-2 infections and has as its goal to decrease the
spread of disease. CDC HICPAC. March 24, 2022. Download Written Comment:
https://www.healthwatchusa.org/downloads/20220324-CDC-PublicComment%20-%20Final.pdf
=========================================================
To Whom It May Concern:
During the COVID-19 pandemic there has been inadequate safety
precautions for front line workers and the public. Politico recently had
a disturbing report of some hospitals removing
patients’ N95 masks and replacing them with surgical masks.1 One of the
facilities mentioned was the Massachusetts General Hospital, the CDC
Director’s prior facility. Patients should be al-lowed to keep their N95
masks or be given a new N95 mask. Surgical masks are unlikely to provide
adequate protection for either Omicron or the BA.2 variant. N95 masks
have superior filtration and facial fit. The CDC needs to require
uniform use of N95 masks in healthcare settings for both patients and
staff.
The new guidelines of community risk zones for COVID-19, may not be
optimal for the
promotion of patient safety. The current guidelines have a threshold of
200 cases per 100,000 population per 7 days2 before there is an effect
on community recommendations. Current risk zone determinations are
largely based upon hospital capacity and not the risk of acquiring
SARS-CoV-2. However, they are used to determine implementation of
masking advisements and other public health strategies. These guidelines
may be problematic.
Ø First, hospitalizations are a lagging indicator in a pandemic. By the
time hospitalizations have increased, the virus is already firmly
established in the community and weeks of continued elevations in
hospitalizations and deaths will occur.
Ø Second, in the medium risk category, it is recommended to wear masks
around someone at high risk for severe disease. This would include up to
50% of the U.S. adult population. But what are these citizens to do when
they need to enter a government building or retail
establishment where no one else is wearing a mask? With the BA.1 and
BA.2 variants, others also need to wear masks to decrease transmission
and viral load as much as
possible.
Ø (In Written Comment Only) Third, there is also a disconnect between
SARS-CoV-2 community levels and hospital capacity. In Kentucky, we have
many counties, which have small critical access hospitals. In these
counties, there may be high SARS-CoV-2 levels, but COVID-19 patients are
often referred to regional medical centers. Conversely, a regional
referral medical center may have many COVID-19 patients but low rates of
SARS-CoV-2 infections in the surrounding community.
Ø Finally, focusing our metrics on hospital capacity, and all but
ignoring mild and moderate disease, overlooks the grave risks of Long
COVID which have been reported to occur in 10 to 30% of COVID-19
patients. Even in mild cases, Long COVID has been recently linked to
both long-term heart disease3 and frequently occurring cognitive
deficits.4
In summary, when masking is required, I would like to encourage the CDC
to require
universal use of N95 masks. And in view of the common and disabling
effects of long COVID, the CDC should revert to a community risk ranking
strategy which is based upon the rate of SARS-CoV-2 infections and has
as its goal to decrease the spread of disease.
Thank you for this consideration,
Kevin T. Kavanagh, MD, MS
Health Watch USAsm
|